Characterizing tobacco use in an American cancer center’s catchment area can help direct future research priorities
Journal Title: Journal of Cancer Research & Therapy - Year 2018, Vol 6, Issue 5
Abstract
Purpose: American cancer centers supported by the National Cancer Institute (NCI) must ensure that their research addresses the cancer relevant needs and risks of members of their catchment area. In 2016, the NCI supported catchment area assessments. This is the first study to describe a cancer center catchment area cancer risk evaluation, focusing on tobacco use and lung cancer screening. Methods: A cross-sectional survey was conducted in 2017 with 1,005 residents within a Philadelphia cancer center catchment area to identify the rate and correlates of smoking and rate of lung cancer screening. Results: The rate of current smoking in the catchment was 13%. Current smokers were more likely to have depression/anxiety, less likely to be eating healthy, more likely to use e-cigarettes, and endorsed lower perceived health and higher cancer fatalism, vs. former (27%) or never smokers; 74% of smokers want to quit smoking, but two-thirds think nicotine dependence medications are unsafe and ineffective, which may be addressed with personalized treatment. E-cigarette use was 11% and lung screening rates were < 30%. Conclusions: These results indicate that addressing tobacco use in the cancer center’s catchment may require targeting comorbid psychiatric conditions and additional cancer risk behaviors such as poor diet, modifying cancer beliefs that may undermine cessation, and utilizing novel methods to promote utilization of evidence-based treatment for smoking. E-cigarette use should be targeted, as well as identifying methods to promote lung screening. This study shows how a cancer center can identify catchment area needs to plan research that reduces the burden of cancer among their residents.
Authors and Affiliations
Robert Schnoll, Sheila Kelly, Andrew Miele, Karen Glanz
Keywords
Related Articles
- EP ID EP529801
- DOI 10.14312/2052-4994.2018-5
- Views 72
- Downloads 0
Usefulness of the Glasgow prognostic score for predicting survival in patients with resected non-small cell lung cancer
Background: Few studies have investigated whether the Glasgow prognostic score (GPS), an inflammation based prognostic score, is useful for postoperative prognosis of non-small cell lung cancer (NSCLC). Materials and met...
Economic evaluation of monoclonal antibody in the management of colorectal cancer
Objective: This study aims to determine the cost of colorectal cancer (CRC) management and compare the cost effectiveness of cetuximab and bevacizumab in the management of CRC. Method: This economic evaluation study from...
Structural imaging of the pancreas in rat using micro-CT: application to a non-invasivelongitudinal evaluation of pancreatic ductal carcinoma monitoring
The aim of the study was to evaluate the feasibility of a longitudinal non-invasive monitoring of rat pancreatic ductal adenocarcinoma (PDAC) using microCTscans (μCT). The identification of the pancreatic gland on (μCT)...
The positive sentinel lymph node biopsy- can we predict which patients will benefit from further surgery?
Introduction: Although sentinel lymph node biopsy (SLNB) is the gold standard for clinical and radiological negative axillae in breast cancer, the subsequent management of positive nodes is currently under scrutiny with...
Pseudocystic pheochromocytoma: An incidental finding and a rare entity
Cystic adrenal neoplasms are uncommon and may be incidentally discovered during radiologic procedure not directly performed for the evaluation of adrenal disease. Cystic pheochromocytomas are uncommon neoplasms that orig...